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Epithelial, stem-cell derived organoids are ideal building blocks for tissue
engineering, however, scalable and shape-controlled bio-assembly of epithelial
organoids into larger and anatomical structures is yet to be achieved. Here, a
robust organoid engineering approach, Multi-Organoid Patterning and Fusion
(MOrPF), is presented to assemble individual airway organoids of different
sizes into upscaled, scaffold-free airway tubes with predefined shapes.
Multi-Organoid Aggregates (MOAs) undergo accelerated fusion in a
matrix-depleted, free-floating environment, possess a continuous lumen, and
maintain prescribed shapes without an exogenous scaffold interface. MOAs
in the floating culture exhibit a well-defined three-stage process of
inter-organoid surface integration, luminal material clearance, and lumina
connection. The observed shape stability of patterned MOAs is confirmed by
theoretical modelling based on organoid morphology and the physical forces
involved in organoid fusion. Immunofluorescent characterization shows that
fused MOA tubes possess an unstratified epithelium consisting mainly of
tracheal basal stem cells. By generating large, shape-controllable organ tubes,
MOrPF enables upscaled organoid engineering towards integrated organoid
devices and structurally complex organ tubes.
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1. Introduction
Engineered fusion of multicellular materi-
als, such as spheroids and organoids, rep-
resents a biomimetic cell assembly process
fundamental to the fields of biofabrica-
tion, tissue engineering and in vitro tissue
modelling,[1,2,3] Organization and fusion of
cell aggregates to achieve prescribed shapes
(and functions) depends on the selection of
initial multicellular building blocks. Coa-
lescence of solid-core spheroids can readily
occur via so-called “tissue liquidity”,[4]
in small aggregates of epithelial cells,[1]
fibroblasts,[5] mesenchymal stem cells,[6]
and in hybrid spheroids consisting multi-
ple cell types.[7,8] Guided-assembly through
micro-fabricated molds or 3D-printing
can further define the three-dimensional
(3D) architecture of engineered tissues.[9]
However, due to the diffusion limit, fused
tissue constructs from solid-core spheroids
are hardly upscaled to viable thick tissues
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beyond millimeter scale, without additional perfusion platforms
or an engineered vasculature.[3] In the last decade, a class of self-
organizing multicellular material called organoids have emerged
as a powerful tool to study the behavior of their tissue of
origin.[10,11,12] Given their close resemblance to native organs in
histology and cell composition, organoids represent ideal modu-
lar units for the biofabrication of biomimetic organs.[13,14] While
fusion has been demonstrated in pairs of brain organoids [15,16]
and in collagen-embedded intestinal organoids,[17] the resultant
fused products do not exhibit organ-scale size and anatomi-
cal shape. Upscaled fusion of cystic epithelial organoids into
shape-controllable, large lumenized tissues is challenging. This
is because to produce large, functional epithelial tubes with an
elongated lumen, such as the trachea, fusion of organoid cysts
requires not only the seamless surface integration between ad-
jacent organoids but also the interconnection of their fluid-filled
lumina.
Here, using mouse tracheal epithelial organoids, we show
Multi-Organoid Patterning and Fusion (MOrPF) to create lum-
enized, macroscale epithelial tubes with defined shapes. We pat-
terned individual organoids into shape-defined Multi-Organoid
Aggregates (MOAs) and employed a free-floating environment
to encourage inter-organoid surface connection and lumeniza-
tion. Notably, the size of fused organ tubes could be prescribed to
match that of an adult mouse trachea. A theoretical model is pro-
posed to explain MOA shape maintenance post-patterning, in the
absence of a solid matrix or shape-supporting scaffold interface.
We envisage these MOA tubes as a foundation for several emerg-
ing downstream applications, including organoid-microfluidics
integration and multi-tissue organ reconstruction.
2. Results
2.1. MOAs Undergo a Three-Stage Fusion Process Leading to
Lumenized Tube Formation
Starting with individual airway organoids derived from adult
mouse tracheal epithelial cells, we established a robust organoid
fusion platform, for the upscaled engineering of size-relevant
epithelial organ tubes (Figure 1a). Isolated single tracheal basal
stem cells form cystic airway organoids of heterogeneous sizes in
3D Matrigel (a mouse-derived extracellular matrix), as previously
reported[18] (Figure S1a, Supporting information). Occasionally,
we observed pairs of organoids fused into randomly shaped cysts
Dr. K. Ouaras, Dr. Y. Y. S. Huang
Department of Engineering
University of Cambridge
Cambridge, CB2 1PZ, UK
E-mail: yysh2@cam.ac.uk







Cambridge, CB3 0HE, UK
(Figure S1b, Supporting information). To test whether liberating
organoids from Matrigel would enhance inter-organoid interac-
tion and fusion, we mechanically dissociated airway organoids
from Matrigel, and cultured them in a free-floating condition
(termed “Matrigel-depleted culture”). Though a small amount
of Matrigel could be carried over into the MOrPF process, this
should not be enough to form a constraining layer around
organoid surfaces. In this Matrigel-depleted condition, organoids
fused more frequently and formed interconnected lumina (Fig-
ure S1c-d, Supporting information); however, the size and shape
of fused products remained heterogeneous. To control the final
geometry of fusion products and to improve overall fusion ef-
ficiency, we developed a multiorganoid patterning and fusion
(MOrPF) workflow as shown in Figure 1a-II. Day-12 organoids
were dissociated from Matrigel drops and transferred in a 3D-
designed polydimethylsiloxane (PDMS) mold to form shape-
patterned multiorganoid aggregates (MOAs). Depending on the
PDMS template size and airway organoid diameter, approxi-
mately 100–1400 organoids were assembled in each well of the
PDMS mold. Subsequently, MOAs were released from the PDMS
template and cultured in the floating condition for effective fu-
sion and lumenization.
We quantified the overall morphological changes of MOA dur-
ing the MOrPF process by measuring the projected area of the
MOA in relation to its inner dense matter (cellular materials in
the center of organoids and MOAs), across different stages of
MOrPF (Figure 1b, Figure S2a, Supporting information). Upon
release from the PDMS mold, the patterned MOA retained its
prescribed geometry with an opaque appearance (Day 1). An ex-
ternal layer of cells started to envelop the outer surface of the
MOA (Day 3, envelopment), leading to the smoothening of the
MOA external contour by Day 6. During this time, the lumi-
nal content of the MOA gradually cleared out (Figure 1b(ii)), as
quantified by the MOA opacity parameter, i.e., the Apparent In-
ner Matter Ratio (AIMR) (Figure 1b(iii)). By Day-10, the MOA
resembled a quasi-translucent, closed-end tube (which signifies
the completion of lumenization in this MOA), exhibiting inter-
mittent lumen shrinkage (Day 12) and re-expansion (Day 15).
Similar lumen shrinkage and re-expansion have been observed
in single epithelial organoids[19] and mouse blastocytes,[20] ow-
ing to a hydraulic control mechanism that restricts cyst size via
luminal pressure-induced epithelium rupture and fluid release.
Note that although the absolute amount of inner matter in this
MOA stopped decreasing after Day 10 (Figure 1b(ii)), the rela-
tive percentage of inner matter, represented by the AIMR, started
to oscillate in the meantime around a stable value of ∼0.35.
This is in accordance with the oscillating MOA size after lu-
menization (Day 10, Figure 1b(ii)), possibly due to inner fluid
loss and re-buildup through the mechanism of hydraulic size
regulation.
Since the time required for MOA fusion increases with the
increase in MOA size (Figure S2f, Supporting information), we
chose AIMR, instead of days in culture, to normalize the fusion
stages among MOAs of different sizes. By correlating AIMR dy-
namics with bright field images, we identified three critical stages
during MOA fusion progression: Stage I: Envelopment and Com-
paction; Stage II: Lumen Clearance; and Stage III: Stabilization
(Figure 1c). These key stages were typical for patterned MOAs of
a range of sizes (Figure S2b-d, Supporting information). During
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Figure 1. MOrPF technique guides the spatial assembly and fusion of airway organoids into upscaled, lumenized epithelial tubes. a) Schematic rep-
resentation of I) mouse airway epithelial organoid generation and the II) MOrPF procedure. Scale bar = 4 mm. b) i) Representative image sequences
(four independent experiments) of a developing MOA. The MOA was patterned in a PDMS well on Day 0 and released into the floating culture on
Day 1. Scale bar = 1 mm; ii) Dynamics of MOA fusion represented by the projected MOA area (black curve) and the inner matter area (blue curve);
iii) quantification of AIMR dynamics, approximating into a three-stage process. AIMR (Apparent Inner Matter Ratio) = MOA area/Inner matter area.
c, Schematic representation of the three stages in MOA fusion. MOA grey value corresponds to the AIMR scale. d) Aspect ratio of stabilized MOAs
as a function of their initial aspect ratio prescribed by the PDMS mold. n = 26 samples, from six independent experiments (each represented with
a different color symbol). e, Representative images (four independent experiments) of engineered MOA tubes with a range of sizes and shapes.
Scale bar = 1 mm.
Stage I, MOAs acquired an outer layer of enveloping cells and
underwent compaction, showing a peak AIMR value ∼0.9 (Fig-
ure 1b(iii), Figure S2d, Supporting information). During Stage
II (the longest stage in MOrPF), MOAs gradually cleared their
luminal content, resulting in a decrease in AIMR from ≈0.9
to ≈0.35 (Figure 1b(iii), Figure S2d-e, Supporting information).
From Stage III, stabilized MOAs developed a smooth outline and
a quasi-translucent lumen, while retaining the aspect ratio pre-
scribed by the PDMS mold (Figure 1d,e). Together, our data sug-
gest that MOrPF is a robust process for the assembly and fu-
sion of small, heterogeneously-sized organoids into macro-scale,
shape-definable epithelial tubes.
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2.2. Inter-organoid Envelopment during Stage I is a Prerequisite
for MOA Fusion
We next investigated organoid behaviors throughout the MOA
fusion process by live imaging small clusters of organoids cul-
tured under different Matrigel concentrations. We first observed
organoid aggregation and cellular bridge formation (termed
“inter-organoid envelopment”) between adjacent, contacting
organoids in the floating culture (Figure 2a(i)). After dissociation
from Matrigel, those organoids were able to aggregate sponta-
neously. Upon establishment of inter-organoid contact, a cellular
bridge started to form between the contacting organoids and con-
tinued to expand into a shared envelope covering those organoids
(Figure 2a(ii), Video S1, Supporting information). Within a few
days, inter-organoid envelopes became visible at multiple loca-
tions on an MOA, gradually integrating into a continuous layer
which encased all organoids within the aggregate (Figure S3a,
Supporting information). Interestingly, organoid aggregation
and envelopment was significantly reduced with increased
Matrigel concentration, as supported by our comparative data in
Gel-suspension (Matrigel added at a 20% volume concentration
in medium, Figure 2b, Figure S3b, Supporting information)
and 100% Matrigel-embedded cultures (Figure 2c, Figure S3d-e,
Supporting information). In the Gel-suspension condition, inter-
organoid enveloping efficiency dropped to below 30% (Figure 2e)
and the onset of envelopment was delayed after organoids had
established contact (Figure 2b(ii)). When embedded in 100%
Matrigel, organoids rarely aggregated or developed envelopes,
even in close proximity (Figure 2c–e). Without efficient en-
velopment, MOAs failed to develop fused lumina (Figure 2f).
Fusion efficiency in MOAs (with projected area of 0.6–1 mm2)
was <20% in Gel-suspension and <10% in Matrigel-embedded
cultures (Figure 2f). By contrast, in the floating condition, over
60% of organoids formed lumenized MOAs by Day 7, which
further increased to over 90% by Day 11. To further explore
organoid fusion capability in the presence of a non-adherent
hydrogel such as agarose, we placed organoids in a floating cul-
ture supplemented with 0.5% weight percent agarose. Organoid
aggregation and envelopment were not affected by agarose frag-
ments, but the lumen clearing process seemed restricted (Figure
S3f, Supporting information). Together, these data suggest that
envelope formation is a prerequisite for organoid fusion and
lumen connection. Inter-organoid envelopment is enhanced in
the floating culture depleted of adhesive Matrigel matrix, which
largely liberates organoids from organoid-substrate interaction,
while permitting organoid-organoid interaction.
2.3. Cellular Matter Release Results in MOA Lumen Clearance
After the establishment of a shared envelope, we further observed
MOA compaction and inner matter release, using live imaging
on MOAs with a 2-day interval, over 8 days. Coinciding with enve-
lope extension, the inter-organoid space decreased within MOAs
(Figure 3a), allowing increased interfacial contact between adja-
cent organoids (Video S2, Supporting information). During the
lumen clearing stage, MOAs developed large, connected cavities
by releasing their inner contents (termed “inner matter release”)
from multiple epithelium rupture sites (Figure 3b(i), Video S3-4,
Supporting information). Notably, immunofluorescent (IF) stain-
ing revealed that there were no apoptotic luminal cells during
the lumen clearing process (Figure S6). Given that the AIMR of
MOAs gradually stabilized by the end of Stage II-lumen clear-
ance, we asked whether the local release of inner matter cor-
related with the ensemble-level MOA opacity. Following the lo-
cal release dynamics of MOAs in their early (AIMR>0.8), mid
(0.4<AIMR<0.7) and late (AIMR<0.4) lumenization phases, we
found that MOAs extruded inner matter in an intermittent, “start
and stop” fashion (Figure S4, Supporting information), which
could take from a few hours to several days at one release site. We
then calculated the local release speed, by quantifying the hourly
increase in the projected area of a released cluster. As shown in
Figure 3b(ii), going from the early, to mid and late lumen clear-
ing phases, both the mean and the maximum release speeds de-
creased, indicating the accomplishment of lumenization and the
stabilization of MOAs.
2.4. MOA Shape Stability during Fusion can be explained by a
Theoretical Model based on Airway Organoid Morphology and
Physical Forces
Since MOAs retain their prescribed, elongated shapes in the
floating culture for weeks (Figure 1d,e), we postulated that such
shape stability could originate from the characteristic airway
organoid morphology, i.e., fluid-filled cysts enclosed by an ep-
ithelial layer (which was treated as an epithelial “shell” in the
context of the following physical model). We examined the phys-
ical forces at play during the organoid fusion process, the bal-
ance of which determines the overall shape of a fused MOA. To
construct a simple mathematical model of organoid fusion and
MOA shape maintenance, we consider a pair of spherical, equal-
sized epithelial organoids (Figure 3c(i)), each of overall thickness
d (the pseudostratified layer of epithelial cells), filled with incom-
pressible fluid. Before fusion, the organoids (which had grown
for 12 days post-plating in Matrigel) are assumed to have a ra-
dius R0. Observations showed that upon their contact, a stable
dumbbell-like structure would form (Figure 3c(iii)), consisting
of two spherical caps of a new radius R, and an interfacial ad-
hesion “disk” in between, which is flat when the two organoids
were of the same radius initially. To preserve their inner volume,
each organoid shell has to be stretched, which causes an elastic
energy penalty,[21,22] in their outer surfaces (see Additional infor-
mation and Figure S5, Supporting information for details). This
energy cost, defined by the elastic modulus G of the epithelial
shell, balances against the energy gain from the adhesion disk
due to the favorable surface energy 𝛾 ,[23,24] These two competing
factors determine the shape of the fused object, before the grad-
ual disintegration of the interfacial disk, which takes a few days to
weeks. The preferred shape of the fused organoids is given by the
plot of the spherical cap height h, as a function of a single control
parameter: the non-dimensional ratio Gd/𝛾 (Figure 3c(ii)).
Taking the measured values of G = 200 Pa[21] and d = 20 µm,
and the estimated adhesion energy at the initial cell-cell contact:
𝛾 = 2 mN m−1, we find the control parameter Gd/𝛾 = 2, and the
predicted height: h = 0.5R0. The observed shape of the organoid
dumbbell (Figure 3c(iii)) is almost exactly matching this predic-
tion of h ∼ 0.5R0, suggesting that our presented model based on
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Figure 2. Inter-organoid envelopment is a prerequisite for MOA fusion. a–c) Live imaging and quantification of inter-organoid envelope dynamics in
Floating (a), Gel suspension (b) and 100% Matrigel (c) cultures. a(i), b(i), c(i), Representative image sequences (three independent experiments)
highlighting changes in inter-organoid gaps and the envelope leading edge positions for the three culture systems. Scale bars = 100 µm. a(ii), b(ii), c(ii),
Measurement of inter-organoid gaps and envelope lengths for the corresponding organoids shown in the left panel. d, Percentage of organoids closing
inter-organoid gaps (less than 80 µm) in the three culture systems. Floating, n = 20; Gel suspension, n = 15; 100% Matrigel, n = 20. e, Percentage of
closely-spaced organoids developing new envelopes daily in the three cultures. Floating, n = 193; Gel suspension, n = 331; 100% Matrigel, n = 449.
Data are presented as mean ± SD. f) Percentage of closely-spaced organoids undergoing successful fusion (as marked by the formation of a continuous
lumen) in different culture systems. Midline = median, box = 25th-75th percentiles, Whisker = min and max values. Floating, n = 10; Gel suspension,
n = 17; 100% Matrigel, n = 17.
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Figure 3. Dynamics of MOA compaction a) and inner matter release b) and theoretical accounts for MOA shape stability (c,d) in MOrPF. a(i), Rep-
resentative image sequence (four independent experiments) of MOA compaction via the closure of inter-organoid space. Scale bar = 100 µm. a(ii),
Measurement of envelope length and the projected area of inter-organoid space over time. n = 4 independent samples. Note that upon establishment,
envelopes quickly integrated onto the organoid surfaces, with leading edges untrackable in the following bright-field image sequences. b(i), Represen-
tative image sequence (three independent experiments) of MOA inner matter release. Scale bar = 500 µm. b(ii), Quantification of the released inner
matter per hour in the Early, Mid and Late stages of MOA lumenization. Early, n = 79; Mid, n = 68; Late, n = 70. *P <0.05 by Mann-Whitney U test. c,
Schematic representation of a physical model on MOA shape definition in the early stage of MOrPF. (i), Two organoids (radius R0, shell thickness d)
fuse to form a dumbbell-like structure consisting of two spherical caps with a larger radius R> R0. h denotes how much the two organoids overlap to
form the dumbbell. (ii) Theoretical model predicts the overlapping distance h/R0 as a function of Gd/𝛾 . (iii) Representative image (two independent
experiments) of two overlapping organoids joint by envelopes. Scale bar = 200 µm. d, Schematic representation of MOA shape maintenance in MOrPF.
The dumbbell outer layer fluidizes in 𝜏1 (hours to days). After the disintegration of the adhesion disk in 𝜏2 (days to weeks), the new dumbbell shape will
become the new quasi-equilibrium state, maintained by the high bending rigidity of the epithelial outer layer.
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two competing physical forces is a good description of the initial
scenario in organoid fusion.
Next, we examined how the dumbbell shape established after
the initial inter-organoid envelopment could remain stable over
the stages of inner matter release and lumen interconnection.
Organoid shell rupture can result in fluid release, and conse-
quently, the release of the weakly bound inner matter material.
Such release events equilibrate the external and internal fluid
pressure, when the inner matter release stops. Another plau-
sible pressure equilibration event could arise from the cellular
plastic flow adjusting the area of the dumbbell shell. With this
auto-pressure regulation, the inner fluid pressure would not ac-
cumulate excessively even after the disintegration of the inter-
facial disk. This physical insight could explain the intermittent
nature of inner matter release patterns (Figure S4, Supporting
information). After the period of plastic flow (hours to days) of
cells on the outer shell of fused organoids, the elastic tension
will be released, and the internal pressure remains equilibrated.
The new dumbbell shape will become the new quasi-equilibrium
state, maintained by the high bending rigidity of the shell (see the
estimate in Supporting Information) even after the disintegration
of the adhesion disk (days to weeks, Figure 3d). Such elongated
shape was thus maintained throughout MOrPF, after MOAs be-
ing prescribed by the initial patterning process.
2.5. Biological Characterization of Fused MOA Tubes
We next assessed the cellular morphology and epithelial com-
position of MOAs at different stages of the MOrPF process. At
Stage I-Envelopment and Compaction, Hematoxylin and Eosin
(H&E) staining revealed that the development of the MOA en-
veloping cell layer was contributed from the epithelial layers of
individual organoids positioned near the MOA surface (4a). Pro-
ceeding to Stage II-Lumen Clearing, individual organoids were
mostly unidentifiable, and the contour of MOAs became smooth
and continuous. In the MOA center, lumina appeared intercon-
nected though some interfacial discs remained (Figure S3c). Fi-
nally, in Stage III-Stabilization, a continuous lumen developed
in MOAs. IF staining for airway epithelial markers showed long-
term maintenance of airway basal stem cells expressing p63 and
Keratin-5 (Krt5) in MOAs up until, and including, Stage III-
stabilization (Figure 4b,c). Differentiated ciliated cells express-
ing acetylated tubulin (ACT) were observed in early Stage II
MOAs (Figure 4d). However, we observed the gradual loss of
differentiated luminal cells expressing Keratin-8 (Krt8), includ-
ing ciliated cells, and an increased disorganization of the typi-
cal pseudostratified airway epithelium over the fusion process
(Figure 4c, Figure S7). To better understand the cellular pro-
cesses responsible for inter-organoid interactions, we examined
Figure 4. Biological characterization of MOA tubes. a, Representative H&E staining (three independent experiments) of an unfused airway organoid
(control) and Stage I to III MOAs. Short arrows indicate “envelope” structures whereas long arrows indicate the remaining “interfacial” disks. Scale
bar = 150 µm. b, Representative immunofluorescent (IF) staining (three independent experiments) of unfused airway organoids and Stage I to III
MOAs for epithelial marker Ecad (green) and basal-cell marker p63 (white). Scale bar = 150 µm. c, Representative IF staining images (two independent
experiments) characterize the Stage I-III MOAs for a pseudostratified epithelium compared to unfused control airway organoids. The outer layer of Stage
I-III MOAs is a single epithelia of Krt5-expressing cells, intermixed with rare Krt8-expressing cells. Krt5 (red), Krt8 (green) and DAPI (blue). Scale bar =
30 µm. d, 3D projection of an early Stage II MOA (day 5 post MOA release), stained for nuclei (blue), Ecad (white), Krt5 (red) and ACT (green). Scale
bar = 370 µm.
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key polarity markers during fusion. Whereas unfused organoids
displayed intact apical-basal polarization, with the basal mem-
brane expressing fibronectin, the apical junction expressing
ZO-1, and the lateral membrane expressing E-cadherin, MOAs
revealed disorganized polarization (Figure S8a, b). Epithelial cells
of stabilized MOAs had reversed polarization, with fibronectin
marking the cellular surfaces facing the central lumen. Fur-
thermore, although epithelial cells in the MOAs maintained ex-
pression of E-cadherin, expression of ZO-1 was significantly
decreased. This is possibly due to the reduction of extracellular
matrix (ECM) proteins after Matrigel depletion during the forma-
tion of MOA.[25] To test whether the apical-basal polarity can be
rescued by the contact of ECM proteins, we re-embedded Stage
II-late phase MOAs (day 10 post MOA release) in Matrigel, fol-
lowed by culturing for 5 days. IF staining showed no notable
changes in the spatial organization of ZO-1 and Fibronectin in
fused MOAs, within a short window of 5 day-culture (Figure S8c,
d). Alternatively, we examined whether the apical-basal polarity
is maintained in MOAs generated by Day-12 organoids in Gel-
suspension culture which uses 20% Matrigel. We indentified the
maintenance of classical airway polarity in these MOAs, suggest-
ing that sustained supply of ECM proteins is important for polar-
ity maintenance (Figure S8e), despite the lower fusion efficiency
compared with the Matrigel-depleted condition as we show in
Figure 2.
Taken together, our data suggest that upon Matrigel depletion
and organoid fusion in the floating condition, fused MOA tubes
retain a single epithelial layer of basal cell identity without pseu-
dostratified epithelial morphology, and show marked changes in
epithelial polarity. MOAs cultured in Gel-suspension maintained
typical airway polarity, but at the cost of reduced fusion efficiency.
In future work, a more balanced ECM concentration, and the
timing of ECM addition in the MOA fusion process needs to be
elucidated, to ensure both efficient organoid fusion and polarity
maintenance.
2.6. Downstream Processing of MOAs for Tissue Engineering
Applications
Since the MOrPF process creates fused airway MOA tubes in a
highly efficient and shape-controllable manner, it opens up pos-
sibilities for scalable organoid device integration, multi-tissue in-
teraction, and organ architecture reconstruction. For example,
fluid transport is characteristic of many organs and plays an im-
portant role in epithelium development and function.[26,27] Our
engineered airway MOA tubes, of a size similar to the mouse
trachea (1–1.5 mm inner diameter[28]), were perfusable and ex-
hibited cyclic lumen expansion and relaxation, in synchroniza-
tion with a peristaltic input flow of culture medium (Figure 5a,
Figure 5. Engineered MOA tubes as scaffold-free biofabrication building modules. a. Application in deviceintegration for a flow-able MOA tube. (i)
Two pulled glass pipettes cannulate the MOA tube and connect its lumen to an external perfusion pump. (ii) Representative image (four independent
experiments) of a MOA tube under media perfusion. Scale bar = 1mm. (iii) Quantification of the MOA lumen area (black curve) in response to a
peristaltic input flow (blue curve). b, Application in tissue integration. (i) Schematic representation of the SMC-MOA tube coculture procedure to form
an integral tissue construct mimicking the mouse trachea. (ii) Representative images (three independent experiments) of the coculture. Scale bar =
1mm. c, Biofabrication via hierarchical MOA fusion. (i) Schematic representation of the assembly and fusion of MOA building blocks, to reconstitute
typical hieratical architecture of branched tubular organs. (ii) Representative images (three independent experiments) of engineered bifurcating epithelial
macrotubes. Scale bars =1 mm.
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Video S5, Supporting information). Such a flow-able system (Fig-
ure S9, Supporting information) is an initial step for recreating
fluid transportation in large engineered organ tubes, where the
lumen is accessible within a closed, controllable system sepa-
rated from the environment on the basal side. It also lays foun-
dation for future studies on epithelial mechanics, as well as for
lung-related drug testing and disease modelling.[29] Additionally,
given that most organ epithelia including the trachea epithelium
are supported by mesenchymal tissues including smooth mus-
cle cells (SMCs), we further engineered a SMC support for fused
airway MOA tubes, by coculturing them with mouse vascular aor-
tic smooth muscle cells (MOVAS). A substrate-detachable SMC
sheet was fabricated using a temperature-responsive plate, and
wrapped around a fused airway MOA tube to create an inte-
grated tissue (Figure 5b). This proof-of-principle coculture exam-
ple illustrates the flexible adaptability of our engineered epithelial
tubes for the biofabrication of complex, multi-tissue organ ana-
logues. Finally, we demonstrated that MOA modular units can be
connected to each other and jointly fused into bifurcating organ
prototypes, mimicking the hierarchical branching architecture in
many epithelial tubes (Figure 5c). The feasibility of fusing mouse
intestinal organoids into 4 mm-long intestinal tubes in our float-
ing system further indicated the broader application of MOrPF
across other types of epithelial organoids (Figure S9c, Support-
ing information).
3. Discussion and Conclusion
Classical bioassembly processes largely rely on solid hydrogel
matrices,[30–32] or patterned scaffolds[5] to both define and main-
tain the architecture of engineered tissues. Recent work demon-
strated that a suspension culture, in place of solid matrices, im-
proves the homogeneity and throughput of individual organoid
culture;[33] however, the sequential self-organizing cellular events
remained unexplored. Here we expand the potential of the float-
ing culture within an organoid assembly workflow, by devel-
oping the MOrPF process that fused individual, heterogeneous
organoids into tissue-scale epithelial tubes of defined geometry.
Such efficient organoid fusion is realized in a Matrigel-depleted,
free-floating system that harnesses the self-organization capacity
of organoids. Importantly, we discovered two critical fusion steps
in MOA fusion and lumenization: inter-organoid surface integra-
tion and subsequent inner matter release. Interestingly, our find-
ings showed great morphological similarities to selected in vivo
epithelial tubulogenesis.[34] The establishment of inter-organoid
envelopes in MOrPF mirrors the formation of protrusion-like
fusion fronts between adjacent tubular branches in the embry-
onic Drosophila trachea[35] and chicken lung.[34] The release of
inner cell matter from MOAs may resemble cavitation (elimina-
tion of redundant cells from a solid-core tissue) in the developing
Drosophila wing[36] and mouse salivary gland.[37] It would be of in-
terest to further investigate the mechanisms of inter-organoid ad-
hesion and cell migration[38] during envelopment, and the mech-
anism of cell release during lumen clearance.
Our study suggests an alternative design pathway for epithe-
lial organoid engineering, in which shape-patterning via mold-
ing is required only at the initial organoid assembly stage, while
the prescribed geometry can be retained long-term in the floating
culture. This is in stark contrast to existing strategies of construct-
ing tubular epithelial structures, which rely on exogenous shape-
supporting matrices or scaffolds.[17,39] Theoretical modelling sug-
gests that the long-term shape stability of patterned MOAs origi-
nates from the biomechanical properties of fluid-filled epithelial
organoid cysts. This also makes the fusion mechanism of cys-
tic organoids distinct from that of solid-core spheroids, in which
shape maintenance is either transient (days), or requires a bound-
ing scaffold or matrix.[1,4,5] Our engineered MOA tubes not only
reproduce the elongated geometry and hollow characteristic of
epithelial organs, but are upscale-able to match the dimension
of the mouse tissues. Interestingly, they reach such macroscopic
scale by employing a lumenization strategy during organoid self-
organization, while circumventing the diffusion limit and vascu-
lature requirement faced by the thick tissue manufacturing via
the fusion of solid-core spheroids. Limitations of our technique
includes the gradual loss of differentiated cells and epithelial po-
larity in fused MOA tubes, which could potentially be improved
with a more balanced ECM composition in the culture environ-
ment.
In summary, MOrPF engineered epithelial tubes are control-
lable and reproducible in geometry, readily accessible for fur-
ther coculture or matrix integration, and compatible with fluidic
techniques to enable lumen access and fluid transport. We en-
visage that such macroscopic tubular epithelial building blocks
could have broad implications in creating size-relevant, struc-
turally complex, multi-tissue organ mimics.[14]
4. Experimental Section
Generation and Culture of Mouse Airway Organoids: Mouse airway
organoids were generated following a published protocol.[40] Experiments
were approved by local ethical review committees and conducted ac-
cording to UK Home Office project license PC7F8AE82. Mice were bred
and maintained under specific-pathogen-free conditions at the Cambridge
Stem Cell Institute and Gurdon Institute of University of Cambridge.
Briefly, trachea was dissected from 7–13 weeks old mice, and incubated
in 50 U mL−1 dispase (Sigma) for 45 min (37 °C). 10 mL PBS was flushed
through the trachea using a syringe needle to release the trachea epithe-
lium. Extracted cell sheets were incubated in trypsin for 5 min (37 °C)
and dissociated single cells were mixed with growth factor-reduced Ma-
trigel (Corning) on ice to a concentration of 1 × 105 cells per mL. 30 µL
dropets of Matrigel-cell mixture was plated in a 48-well plate and left in
incubator for 15 min (37 °C) for gelation. Matrigel droplets were covered
with 250 µL DMEM-Ham’s F-12 media supplemented with 0.5 mg mL−1
penicillin-streptomycin, 10 µg mL−1 insulin, 5 µg mL−1 transferrin, 0.1 µg
mL−1 cholera toxin, 25 ng mL−1 EGF, 30 µg mL−1 bovine pituitary ex-
tract, 5% FBS and 0.01 × 10−6 m retinoic acid. Media was exchanged every
2 days.
Design and Fabrication of MOA Shape-Pattering Molds: Negative Poly-
lactic acid (PLA) molds with convex, tubular features (1–5 mm in length,
0.8–1.5 mm in width, 1 mm in height) were designed in Autodesk Inven-
tor Professional 2018 software and printed with an Ultimaker 3D printer.
PDMS (Sylgard 184) and curing agent is mixed at 10:1 ratio and degassed
in a desiccator for 1 h. The mixture was poured onto the PLA mold and
placed in an oven at 60°C for 6 h. After curation, PDMS containing arrays
of concave wells was peeled from PLA and immersed in ethanol for 18 h
to remove uncured PDMS. The PDMS mold was then autoclaved and im-
mersed in an anti-cell adherence solution (STEMCELL, Catalogue 0 7010)
for 1 h. After removal of the anti-adherence coating, PDMS molds were
washed with PBS three times and to dry for use as a template for MOA
shape pattering.
Adv. Sci. 2021, 8, 2003332 © 2021 The Authors. Advanced Science published by Wiley-VCH GmbH2003332 (9 of 11)
www.advancedsciencenews.com www.advancedscience.com
MOA Patterning via Molding: Day-12 organoids were harvested from
Matrigel and centrifuged at 500 × g for 5 min (0°C). Supernatant was dis-
carded and organoid pellet was resuspended with cold media (0 °C), to
remove residual Matrigel on the organoid surface. Organoids underwent
a second centrifugation at 500× g for 5 min (0 °C) to form a compact pellet.
Supernatant was removed and the organoid pellet was carefully pipetted
into the PDMS shape-patterning wells until the concave space was filled.
To recreate mouse trachea anatomy (1–1.5 mm inner diameter), airway
organoids were assembled within tubular wells of the same dimension
(1–1.5 mm in width, 2–6 mm in length, 1 mm in height). MOAs were then
overlaid with media and incubated in PDMS molds overnight to acquire
the prescribed shape via contact guidance. Subsequently, MOAs were re-
leased from PDMS molds and cultured in a media-only condition in ultra-
low attachment 6-well plates (Corning).
MOA Formation via Pipette Extrusion: Day-12 organoids were har-
vested from Matrigel and centrifuged at 500 × g for 5 min (0°C). Super-
natant was discarded and organoid pellet was resuspended with cold me-
dia (0°C), to remove residual Matrigel on the organoid surface. Organoids
underwent a second centrifugation at 500 × g for 5 min (0°C) to form a
compact pellet. Upon supernatant removal, organoid pellet was sucked
into a 200 µL pipette tip and manually extruded into a string-like shape in
warm media. The string-shaped aggregates were cultured long-term in a
media-only, ultra-low attachment 6-well plate (Corning).
Image Acquisition and Analysis: Bright-field images of MOAs were ac-
quired daily using an Olympus optical microscope with 4x and 10x ob-
jectives. The projected area of MOAs was measured using ImageJ soft-
ware. For AIMR ( = MOA area/inner matter area) quantification, optical
images were corrected with background subtraction and converted into
binary masks using the threshold function in ImageJ.
Time-lapse imaging was acquired by using a confocal spinning-disk mi-
croscope system (Intelligent Imaging Innovations, Inc. 3i). The imaging
system was composed of an Observer Z1 inverted microscope (Zeiss),
a CSU X1 spinning disk head (Yokogawa), and a Quant EM 512SC cam-
era (Photometrics). Silicon micro-inserts (4 well, Ibidi) were inserted into
each well of an uncoated 8-well µ-slide (Ibidi). 8–12 Matrigel-depleted
organoids were positioned within close proximity (less than 80 µm) in each
mini-compartment created in the µ-slide. Organoids were grouped into
three culture conditions: Floating, Gel-suspension (culture media supple-
mented with 20% volume fraction Matrigel in suspension) and the conven-
tional Matrigel droplet culture. The µ-slide was mounted in a mini imaging
compartment with controlled temperature (37°C) and CO2 concentration
(5%). Organoid behaviours were recorded every 2 days with a 10x objec-
tive over a 10-day observation period. A x, y, z scanning mode was used
to obtain z stack images. 3D image reconstruction and quantification of
organoid dynamics (inter-organoid gap, envelope length, projected area
of released inner matter) were performed in Slidebook6 software.
Immunofluorescent and Histological Staining: For immunofluorescent
study, MOAs were prepared via pipette extrusion. MOAs at early-
lumenization, mid-lumenization and stabilization stages were fixed with
4% paraformaldehyde (PFA) for 1 h and washed three times with PBS in a
fume hood. For immunofluorescent staining, fixed samples were perme-
abilized in 0.2% Triton X-100 in PBS for 1 h, then blocked in 2% normal
donkey serum (NDS) in PBS for 1 h at room temperature. Primary anti-
bodies (in 5% NDS/PBS solution at 1:200) were added and left overnight
at 4 °C, then washed off with 0.2% Tween-20 in PBS. Secondary antibod-
ies were (in PBS at 1:2000) incubated for 1 h at room temperature, then
washed off with 0.2% Tween-20 in PBS. For staining DNA, DAPI (1:1000
dilution) was used for 5 min at room temperature. Antibodies are listed in
the Supporting Information.
For histological staining, fixed samples were embedded in paraffin wax
and sectioned on a xyz microtome. Hematoxylin and eosin were used as
dyes to stain respectively the cell nucleus (blue) and cytoplasm (pink).
Design and Fabrication of a Perfusion Chip for MOA Tubes: The milliflu-
idics perfusion device was composed of a single-channel PDMS chip and
a pair of pulled glass capillaries (1 mm outer diameter). A PLA template
for the PDMS chip was designed in Autodesk inventor 2018 and printed
with an Ultimaker 3D printer. A syringe needle (1 mm outer diameter) was
assembled in the PLA construct, before pouring the PDMS-curing agent
mixture (10:1) into the PLA mold. After curing (60°C, 6 h), the needle was
removed and PDMS was peeled from the PLA, followed by an immersion
in ethanol for 18 h. A 4 mm hole was punched in the centre of the PDMS
chip, as a space to accommodate the MOA tube. The PDMS chip was then
bonded with a thin glass slide using a plasma cleaner (Harrick plasma)
and autoclaved before use.
A MOA tube was placed in the central culture area and Matrigel was
added to fill the remaining culture space. The chip was incubated for
15 min to allow Matrigel gelation, followed by a top-up of the media reser-
voir with warm media. The airway-on-a-chip was stabilized in the incubator
for at least 6 h before mounted on an Olympus SZX16 upright optical mi-
croscope. Two glass capillaries were prepared using a micropipette puller
(Sutter Instrument) and cut into 50 µm tip diameter with a micro forge
(Narishige). Capillaries were autoclaved and prefilled with culture media
before insertion through the two ports of the PDMS chip. The inlet and out-
let capillaries were connected to a Fisherbrand peristaltic pump through
a media prefilled silicone tubing, and carefully advanced toward the MOA
tube to cannulate the lumen. Direction and velocity of the media flow were
tuned by controlling the rotating direction (clockwise or anti-clockwise)
and speed (level 1–10) of the rotors. Flow rate calibration was performed
prior to perfusion by recording the weight change of media droplets flow-
ing from the silicone tubing.
Engineered Coculture of SMCs and MOA Tubes: Mouse vascular aor-
tic smooth muscle cells MOVAS (ATCC CRL-2797) were purchased from
ATCC and cultured in DMEM (DB) supplemented with 10% FBS and an-
tibiotics. To form SMC sheets, SMCs were passaged on 80% confluence
and incubated in a temperature-responsive Nunc Dishe with UpCell Sur-
face (ThermoFisher). When cells reached confluence, the UpCell plate was
transferred to room temperature (20 °C) to initiate temperature-regulated
cell sheet detachment. SMC medium was discarded, and a MOA tube was
placed atop of a SMC sheet. Subsequently, the SMC sheet was careful lifted
from the well bottom using forceps and wrapped around the MOA tube,
to create the coculture construct. Organoid media was then added to the
assembled tissue, which was cultured for 5 days before antibody staining.
Statistical Analysis: All statistical analyses were performed in Origin-
Lab 2015 software. For normally distributed data sets with equal variances,
two-sample t-test was used. When normal distribution and equal variance
were not met, Mann-Whitney U test was performed. P values less than
0.05 were considered statistically significant. All box plots extend from the
25th to 75th percentiles, with a line at the median and whiskers extending
to maximum and minimum data points. Each experiment was repeated at
least twice.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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